About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Clinical Nuclear Medicine
›
top-articles
Clinical Nuclear Medicine
1.3
(top 50%)
impact factor
17.5K
(top 1%)
papers
111.4K
(top 5%)
citations
74
(top 10%)
h
-index
1.4
(top 50%)
impact factor
18.9K
all documents
116.2K
doc citations
99
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Choline PET or PET/CT and Biochemical Relapse of Prostate Cancer
Clinical Nuclear Medicine
2013
255
2
Brain PET in the Diagnosis of Alzheimer’s Disease
Clinical Nuclear Medicine
2014
239
3
F-18 FDG Uptake in the Large Arteries
Clinical Nuclear Medicine
2001
229
4
Clinical Experience with Tc-99m MIBI Imaging in Patients with Malignant Tumors Preliminary Results and Comparison with TI-201
Clinical Nuclear Medicine
1992
171
5
Split Renal Function Testing Using Tc-99m DTPA
Clinical Nuclear Medicine
1983
169
6
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
Clinical Nuclear Medicine
2016
165
7
Exclusion of Chronic Osteomyelitis With F-18 Fluorodeoxyglucose Positron Emission Tomographic Imaging
Clinical Nuclear Medicine
2000
161
8
Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer
Clinical Nuclear Medicine
2016
153
9
SPECT Brain Perfusion Abnormalities in Mild or Moderate Traumatic Brain Injury
Clinical Nuclear Medicine
1998
152
10
Uptake and Kinetics of Tc-99m Hexakis 2-Methoxy Isobutyl Isonitrile in Benign and Malignant Lesions in the Lungs
Clinical Nuclear Medicine
1989
151
11
F-18 Fluorodeoxyglucose Chest Uptake in Lung Inflammation and Infection
Clinical Nuclear Medicine
2000
149
12
Evaluation of Chemotherapy Response in Primary Bone Tumors with F-18 FDG Positron Emission Tomography Compared with Histologically Assessed Tumor Necrosis
Clinical Nuclear Medicine
2000
148
13
Image Analysis in Patients with Cancer Studied with a Combined PET and CT Scanner
Clinical Nuclear Medicine
2000
142
14
Whole-Body FDG Positron Emission Tomographic Imaging for Staging Esophageal Cancer
Clinical Nuclear Medicine
2000
137
15
Diagnosing Spinal Osteomyelitis
Clinical Nuclear Medicine
2000
136
16
SPECT Brain Imaging Abnormalities in Attention Deficit Hyperactivity Disorder
Clinical Nuclear Medicine
1995
134
17
Low-Dose Oral Propranolol Could Reduce Brown Adipose Tissue F-18 FDG Uptake in Patients Undergoing PET Scans
Clinical Nuclear Medicine
2007
129
18
Prospective Evaluation of 18F-NaF and 18F-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer
Clinical Nuclear Medicine
2012
125
19
F-18 FDG Whole-Body PET for the Assessment of Disease Activity in Patients With Rheumatoid Arthritis
Clinical Nuclear Medicine
2006
122
20
The Role of Fluorine-18 Deoxyglucose Positron Emission Tomography in the Management of Patients With Metastatic Melanoma: Impact on Surgical Decision Making
Clinical Nuclear Medicine
2003
119
21
FDG Positron Emission Tomography in the Surveillance of Hepatic Tumors Treated with Radiofrequency Ablation
Clinical Nuclear Medicine
2003
119
22
F-18 FDG PET/CT in the Diagnosis of Fever of Unknown Origin
Clinical Nuclear Medicine
2009
119
23
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse
Clinical Nuclear Medicine
2015
118
24
Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid Carcinoma
Clinical Nuclear Medicine
2012
115
25
Scintigraphic Evaluation of Salivary Gland Dysfunction in Patients with Thyroid Cancer After Radioiodine Treatment
Clinical Nuclear Medicine
2002
114
26
Differentiating Benign from Malignant Lung Lesions Using “Quantitative” Parameters of FDG PET Images
Clinical Nuclear Medicine
1996
114
27
F-18-FDG Uptake in Tuberculosis
Clinical Nuclear Medicine
1998
114
28
Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine (F-18 FET) PET for Glioma Grading
Clinical Nuclear Medicine
2011
113
29
Low Iodine Diet in I-131 Ablation of Thyroid Remnants
Clinical Nuclear Medicine
1983
110
30
Superiority of Iodine-123 Compared with Iodine-131 Scanning for Thyroid Remnants in Patients with Differentiated Thyroid Cancer
Clinical Nuclear Medicine
2001
109
31
Dual-Time Point FDG PET Imaging in the Evaluation of Pulmonary Nodules With Minimally Increased Metabolic Activity
Clinical Nuclear Medicine
2007
109
32
Whole-Body Scintigraphy With Radioiodine-131 A Comprehensive List of False-Positives With Some Examples
Clinical Nuclear Medicine
1995
108
33
FDG PET or PET/CT for Detecting Intramedullary and Extramedullary Lesions in Multiple Myeloma
Clinical Nuclear Medicine
2012
107
34
Comparative Evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for Metabolic Imaging of Low Grade Gliomas
Clinical Nuclear Medicine
2009
104
35
Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors—Preliminary Analysis
Clinical Nuclear Medicine
2017
102
36
F-18 FDG Uptake in Breast Infection and Inflammation
Clinical Nuclear Medicine
2000
102
37
A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer
Clinical Nuclear Medicine
2019
101
38
FDG-PET Imaging in Primary Bilateral Adrenal Lymphoma: A Case Report and Review of the Literature
Clinical Nuclear Medicine
2005
96
39
Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism
Clinical Nuclear Medicine
2017
96
40
Hematopoietic Cytokine-Mediated FDG Uptake Simulates the Appearance of Diffuse Metastatic Disease on Whole-Body PET Imaging
Clinical Nuclear Medicine
1998
95
41
Elimination of Artifactual Accumulation of FDG in PET Imaging of Colorectal Cancer
Clinical Nuclear Medicine
1998
94
42
Diagnostic Value of FDG PET and Salivary Gland Scintigraphy for Parotid Tumors
Clinical Nuclear Medicine
2005
93
43
Meta-analysis: Comparison of F-18 Fluorodeoxyglucose-Positron Emission Tomography and Bone Scintigraphy in the Detection of Bone Metastases in Patients With Breast Cancer
Clinical Nuclear Medicine
2008
93
44
Clinical Applications of Hybrid PET/MRI in Neuroimaging
Clinical Nuclear Medicine
2013
92
45
Accuracy of 18F-FDG PET/CT for Diagnosing Inguinal Lymph Node Involvement in Penile Squamous Cell Carcinoma
Clinical Nuclear Medicine
2012
91
46
The Scope of False-Positive lodine-131 Images for Thyroid Carcinoma
Clinical Nuclear Medicine
1989
89
47
A Comparative Study of Fused FDG PET/MRI, PET/CT, MRI, and CT Imaging for Assessing Surrounding Tissue Invasion of Advanced Buccal Squamous Cell Carcinoma
Clinical Nuclear Medicine
2011
89
48
Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in Localization of Tumor Causing Oncogenic Osteomalacia
Clinical Nuclear Medicine
2015
88
49
Therapeutic Responses and Survival Effects of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castrate-Resistant Prostate Cancer
Clinical Nuclear Medicine
2018
88
50
Radionuclide Lymphangioscintigraphy in the Evaluation of Peripheral Lymphedema
Clinical Nuclear Medicine
2000
87
site/software ©
exaly
; All materials licenced under
CC by-SA
.